These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
870 related articles for article (PubMed ID: 33776917)
21. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico. Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598 [TBL] [Abstract][Full Text] [Related]
22. Excess body weight is an independent risk factor for severe forms of COVID-19. Pietri L; Giorgi R; Bégu A; Lojou M; Koubi M; Cauchois R; Grangeot R; Dubois N; Kaplanski G; Valéro R; Béliard S Metabolism; 2021 Apr; 117():154703. PubMed ID: 33421506 [TBL] [Abstract][Full Text] [Related]
23. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events. Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716 [TBL] [Abstract][Full Text] [Related]
24. Obesity and Higher Risk for Severe Complications of Covid-19: What to do when the two pandemics meet. Valerio A; Nisoli E; Rossi AP; Pellegrini M; Todesco T; El Ghoch M J Popul Ther Clin Pharmacol; 2020 Jun; 27(S Pt 1):e31-e36. PubMed ID: 32650354 [TBL] [Abstract][Full Text] [Related]
25. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis. Figliozzi S; Masci PG; Ahmadi N; Tondi L; Koutli E; Aimo A; Stamatelopoulos K; Dimopoulos MA; Caforio ALP; Georgiopoulos G Eur J Clin Invest; 2020 Oct; 50(10):e13362. PubMed ID: 32726868 [TBL] [Abstract][Full Text] [Related]
26. Interrelations between COVID-19 and other disorders. Gasmi A; Peana M; Pivina L; Srinath S; Gasmi Benahmed A; Semenova Y; Menzel A; Dadar M; Bjørklund G Clin Immunol; 2021 Mar; 224():108651. PubMed ID: 33333255 [TBL] [Abstract][Full Text] [Related]
27. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients. Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature. Bajgain KT; Badal S; Bajgain BB; Santana MJ Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414 [TBL] [Abstract][Full Text] [Related]
29. COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention. Sharma JR; Yadav UCS Obes Res Clin Pract; 2021; 15(2):163-171. PubMed ID: 33509701 [TBL] [Abstract][Full Text] [Related]
30. Coronavirus disease 2019 (COVID-19) and obesity. Impact of obesity and its main comorbidities in the evolution of the disease. Cornejo-Pareja IM; Gómez-Pérez AM; Fernández-García JC; Barahona San Millan R; Aguilera Luque A; de Hollanda A; Jiménez A; Jimenez-Murcia S; Munguia L; Ortega E; Fernandez-Aranda F; Fernández Real JM; Tinahones F Eur Eat Disord Rev; 2020 Nov; 28(6):799-815. PubMed ID: 32974994 [TBL] [Abstract][Full Text] [Related]
31. Review of the Metabolic Risk Factors for Increased Severity of Coronavirus Disease-2019. Fishkin T; Goldberg MD; Frishman WH Cardiol Rev; 2021 Nov-Dec 01; 29(6):292-295. PubMed ID: 34261900 [TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115 [TBL] [Abstract][Full Text] [Related]
33. COVID-19 and Cardiovascular Comorbidities. Müller-Wieland D; Marx N; Dreher M; Fritzen K; Schnell O Exp Clin Endocrinol Diabetes; 2022 Mar; 130(3):178-189. PubMed ID: 33157558 [TBL] [Abstract][Full Text] [Related]
34. The COVID-19 Effect on the Immune System and Mitochondrial Dynamics in Diabetes, Obesity, and Dementia. Holder K; Reddy PH Neuroscientist; 2021 Aug; 27(4):331-339. PubMed ID: 32981462 [TBL] [Abstract][Full Text] [Related]
35. COVID-19 and cardiovascular disease: a review of current knowledge. Pal A; Ahirwar AK; Sakarde A; Asia P; Gopal N; Alam S; Kaim K; Ahirwar P; Sorte SR Horm Mol Biol Clin Investig; 2021 Feb; 42(1):99-104. PubMed ID: 33544511 [TBL] [Abstract][Full Text] [Related]
36. Relationship between COVID-19 and obesity. Ekiz T; Pazarlı AC Diabetes Metab Syndr; 2020; 14(5):761-763. PubMed ID: 32505980 [TBL] [Abstract][Full Text] [Related]
37. Comparison of clinical manifestations, pre-existing comorbidities, complications and treatment modalities in severe and non-severe COVID-19 patients: A systemic review and meta-analysis. Giri M; Puri A; Wang T; Guo S Sci Prog; 2021; 104(1):368504211000906. PubMed ID: 33752530 [TBL] [Abstract][Full Text] [Related]
38. COVID-19: a conundrum to decipher. Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923 [TBL] [Abstract][Full Text] [Related]
39. Comorbidities that predict acute respiratory syndrome coronavirus 2 test positivity in Mexican Children: A case-control study. Hernández-Garduño E Pediatr Obes; 2021 May; 16(5):e12740. PubMed ID: 33040467 [TBL] [Abstract][Full Text] [Related]
40. COVID-19 and diabetes: Is there enough evidence? Tadic M; Cuspidi C; Sala C J Clin Hypertens (Greenwich); 2020 Jun; 22(6):943-948. PubMed ID: 32472662 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]